Shire plc ( SHPGY) Q4 2010 Earnings Call February 10, 2011 9:00 am ET Executives Eric Rojas - Director, North America Investor Relations Angus Russell - Chief Executive Officer Graham Hetherington - Chief Financial Office Mike Cola - President, Specialty Pharmaceuticals Sylvie Grégoire - President, Human Genetic Therapies Analysts Ken Cacciatore - Cowen and Company, LLC. Peter Verdult - Morgan Stanley Dean Witter David Buck - Buckingham Research Group Kerry Holford - Credit Suisse David Steinberg - Deutsche Bank Securities Inc. Graham Parry - Merrill Lynch Brian Bourdot - Barclays Capital Frank Pinkerton - SunTrust Robinson Humphrey PresentationOperator
A very good day to you, ladies and gentlemen. Welcome to the Shire 2010 Full-Year Results Conference Call hosted by Angus Russell. My name is Nancy, I'm the operator for the call today. Your lines will remain on listen-only throughout the conference. (Operator Instructions) I'd like to advice all parties this call is being recorded for replay purposes. I would now like to hand the call over to Eric Rojas. Please go ahead. Eric Rojas Thanks, Nancy. Good morning and good afternoon, everyone. Thank you for joining us today for Shire's full-year 2010 financial results. By now you should have all received our press release and should be viewing our presentation via our website on shire.com. If for some reasons you have not received the press release or are unable to access our website, please contact Souheil Salah in our UK Investor Relations Department on +44-1256-894-160 and he will be happy to assist you.